mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.077 |
0.8 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |